Unknown PHASE4 INTERVENTIONAL 2-arm NCT03103685

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Effect of Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving Dual-antiplatelet Therapy Undergoing Dental Procedure.

Sponsor: Chiang Mai University

Conditions Antiplatelet Agents Antiplatelet Drugs Dental Diseases

Interventions Clopidogrel

Updated 5 times since 2017 Last updated: Mar 31, 2017 Started: May 1, 2017 Primary completion: Dec 30, 2018 Completion: Dec 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03103685, this PHASE4 trial focuses on Antiplatelet Agents and Antiplatelet Drugs and remains ongoing. Sponsored by Chiang Mai University, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
May 2017 — Apr 2019 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chiang Mai University

Data source: Chiang Mai University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.